Impact of mitochondrial function on yeast susceptibility to antifungal compounds.
Saccharomyces cerevisiae pell and crd1 mutants deficient in the biosynthesis of mitochondrial phosphatidylglycerol (PG) and cardiolipin (CL) as well as Kluyveromyces lactis mutants impaired in the respiratory chain function (RCF) containing dysfunctional mitochondria show altered sensitivity to metabolic inhibitors. The S. cerevisiae pell mutant displayed increased sensitivity to cycloheximide, chloramphenicol, oligomycin and the cell-wall perturbing agents caffeine, caspofungin and hygromycin. On the other hand, the pel1 mutant was less sensitive to fluconazole, similarly as the K. lactis mutants impaired in the function of mitochondrial cytochromes. Mitochondrial dysfunction resulting either from the absence of PG and CL or impairment of the RCF presumably renders the cells more resistant to fluconazole. The increased tolerance of K. lactis respiratory chain mutants to amphotericin B, caffeine and hygromycin is probably related to a modification of the cell wall.
Sarinová
M
M
Department of Microbiology and Virology, Faculty of Science, Comenius University, 842 15 Bratislava, Slovakia.
Tichá
E
E
Obernauerová
M
M
Gbelská
Y
Y
D000935:Antifungal Agents / Q000494:pharmacology*; D002308:Cardiolipins / Q000235:genetics / Q000378:metabolism; D002473:Cell Wall / Q000502:physiology; D004272:DNA, Mitochondrial / Q000235:genetics; D025141:Drug Resistance, Fungal / Q000235:genetics*; D004579:Electron Transport / Q000187:drug effects / Q000235:genetics; D007716:Kluyveromyces / Q000187:drug effects* / Q000235:genetics; D008826:Microbial Sensitivity Tests; D008928:Mitochondria / Q000235:genetics* / Q000502:physiology; D009154:Mutation; D010715:Phosphatidylglycerols / Q000235:genetics / Q000378:metabolism; D012441:Saccharomyces cerevisiae / Q000187:drug effects* / Q000235:genetics
D000935:Antifungal Agents; D002308:Cardiolipins; D004272:DNA, Mitochondrial; D010715:Phosphatidylglycerols
Biochim Biophys Acta. 1980 Oct 16;602(1):201-6
6998496
Biochem Biophys Res Commun. 2000 Dec 20;279(2):378-82
11118295
Curr Genet. 1996 Jul 31;30(2):145-50
8660461
Curr Genet. 1990 Dec;18(6):517-22
2076551
Yeast. 1998 Dec;14(16):1471-510
9885152
Genetics. 1997 Oct;147(2):435-50
9335584
FEBS Lett. 1998 Jan 2;421(1):15-8
9462830
Curr Genet. 1993 Oct;24(4):307-12
8252640
J Biol Chem. 1998 Apr 17;273(16):9829-36
9545322
Biochem J. 2002 May 15;364(Pt 1):317-22
11988106
J Biol Chem. 1990 Jul 25;265(21):12711-6
2165073
J Biol Chem. 2004 Oct 8;279(41):42612-8
15292198
J Biol Chem. 2001 Dec 21;276(51):47844-52
11602584
J Biol Chem. 2001 Jul 6;276(27):25262-72
11335731
J Biol Chem. 2000 Dec 1;275(48):37347-56
10980204
Genetics. 2001 Nov;159(3):929-38
11729142
Antimicrob Agents Chemother. 2004 May;48(5):1600-13
15105111
Biochem Soc Trans. 2005 Nov;33(Pt 5):1206-9
16246082
J Gen Appl Microbiol. 2001 Feb;47(1):21-26
12483564
Biochemistry (Mosc). 2005 Feb;70(2):154-8
15807653
J Biol Chem. 2003 Sep 12;278(37):34998-5015
12824174
Curr Genet. 1997 Oct;32(4):267-72
9342406
Prog Lipid Res. 2000 May;39(3):257-88
10799718
J Biol Chem. 2003 Sep 12;278(37):35204-10
12840009
FEMS Microbiol Lett. 1996 Jun 15;140(1):43-7
8666200
J Antimicrob Chemother. 2000 Aug;46(2):191-7
10933640
J Biol Chem. 1994 Jan 21;269(3):1940-4
8294444
Biochem Biophys Res Commun. 1968 Feb 15;30(3):232-9
5647224
Mol Biol Cell. 2005 Feb;16(2):665-75
15563612
FEBS Lett. 1974 Jun 15;42(3):309-13
4604022
Antonie Van Leeuwenhoek. 1964;30:1-9
14160070
Res Microbiol. 1998 Feb;149(2):109-18
9766214
J Biol Chem. 2000 Jul 21;275(29):22387-94
10777514
Mol Gen Genet. 1992 May;233(1-2):97-105
1603079
Folia Microbiol (Praha). 2005;50(4):293-9
16408847
Curr Genet. 1998 Oct;34(4):297-302
9799363
J Biol Chem. 2003 Dec 26;278(52):52873-80
14561769
FEBS Lett. 2002 Mar 27;515(1-3):25-8
11943188